| Product | Strength | Indication | GMP | Business Model |
|---|
| Amoxicillin Sodium and Clavulanate Potassium for Injection | 0.5g: 0.1g; 1g: 0.2g | This product can be used for short-term treatment of the following infections: - Upper respiratory tract infections (including ear, nose, and throat): such as recurrent tonsillitis. - Lower respiratory tract infections: such as acute exacerbation of chronic bronchitis, lobar pneumonia, and bronchopneumonia. - Sinusitis. - Otitis media. - Genitourinary tract infections: such as cystitis, urethritis, and pyelonephritis. - Skin and soft tissue infections: such as boils, abscesses, cellulitis, and traumatic infections. - Bone and joint infections: such as osteomyelitis. - Other infections: such as peritoneal infections. This product can also be used to prevent infections in major surgeries, such as gastrointestinal, pelvic, head, neck, cardiac, renal, joint replacement, and biliary tract surgeries. | CN | Dist |
| Amoxicillin Sodium and Sulbactam Sodium for Injection | 0.5g: 0.25g; 1.0g: 0.5g; 2.0g: 1.0g | Indications for infections caused by enzyme-producing resistant bacteria include: 1. Upper respiratory tract infections: such as infections of the ear, nose, and throat, including otitis media, sinusitis, tonsillitis, and pharyngitis. 2. Lower respiratory tract infections: such as pneumonia, acute bronchitis, acute exacerbation of chronic bronchitis, bronchiectasis, empyema, and lung abscess. 3. Genitourinary tract infections: such as pyelonephritis, cystitis, and urethritis. 4. Skin and soft tissue infections: such as cellulitis, wound infections, boils, impetigo, and pustular dermatitis; sexually transmitted diseases; gonorrhea. 5. Pelvic infections: gynecological infections, postpartum infections, etc. 6. Oral abscesses: such as surgical use of medication. 7. Severe systemic infections: such as meningitis, bacterial endocarditis, peritonitis, osteomyelitis, typhoid and paratyphoid fever, and prophylaxis of endocarditis. | CN | Dist |
| Amoxicillin and Clavulanate Potassium Tablets | 0.25g: 0.125g | This product is indicated for various infections caused by susceptible bacteria, including: 1. Upper respiratory tract infections: such as sinusitis, tonsillitis, pharyngitis, etc. 2. Lower respiratory tract infections: such as acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess, and infections associated with bronchiectasis, etc. 3. Urinary tract infections: such as cystitis, urethritis, pyelonephritis, prostatitis, pelvic inflammatory disease, gonococcal urethritis, and chancroid, etc. 4. Skin and soft tissue infections: such as boils, abscesses, cellulitis, wound infections, intra-abdominal sepsis, etc. 5. Other infections: such as otitis media, osteomyelitis, sepsis, peritonitis, and postoperative infections, etc. | CN | Dist |
| Amoxicillin and Clavulanate Potassium for Suspension (4:1) | 250mg/62.5mg | Respiratory tract infections, acute bacterial otitis media, sinusitis, skin and skin structure infections, urinary tract infections, etc. | US, CN | TT |
| Ampicillin Sodium and Sulbactam Sodium for Injection | 0.5g: 0.25g; 1.0g: 0.5g | This product is indicated for infections caused by β-lactamase-producing Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae, Staphylococcus spp., Escherichia coli, Klebsiella spp., Proteus mirabilis, Bacteroides fragilis, Acinetobacter spp., and Enterococcus spp., involving the respiratory tract, hepatobiliary system, urinary tract, and skin and soft tissues. It is particularly suitable for mixed infections with aerobic and anaerobic bacteria, especially intra-abdominal and pelvic infections. It is also effective against infections caused by ampicillin-susceptible bacteria in the aforementioned categories. This product is not recommended for infections caused by Pseudomonas aeruginosa, Citrobacter spp., Providencia spp., Enterobacter spp., Morganella spp., and Serratia spp. | CN | Dist |
| Caspofungin Acetate for Injection | 50mg; 70mg | Fungal injection | US, EU, CN | Dist |
| Caspofungin Acetate for Injection | 50mg; 70mg | This product is intended for use in adult patients and pediatric patients (three months and older): 1. Empirical treatment of suspected fungal infections in neutropenic patients with fever. 2. Treatment of candidemia and the following candidal infections: intra-abdominal abscesses, peritonitis, and pleural space infections. 3. Treatment of esophageal candidiasis. 4. Treatment of invasive aspergillosis in patients who are refractory or intolerant to other therapies (e.g., amphotericin B, liposomal amphotericin B, itraconazole). | CN, US | Dist |
| Cefazolin Sodium for Injection | 1.0g; 0.5g | Indicated for the treatment of the following infections caused by susceptible organisms: otitis media, bronchitis, pneumonia and other respiratory-tract infections; urinary-tract infections; skin and soft-tissue infections; bone and joint infections; septicemia; infective endocarditis; hepatobiliary infections; and infections of the eye, ear, nose and throat. May also be used for peri-operative prophylaxis. | JP, CN | Dist |
| Cefoxitin Sodium for Injection | 1.0g | Infections caused by susceptible bacteria: respiratory tract infections; genitourinary system infections; intra-abdominal infections (including peritonitis and cholangitis); infections of bones, joints, skin, and soft tissues; sepsis. | CN | Dist, TT |
| Ceftazidime for Injection | 0.5g; 1.0g; 1.5g; 2.0g; 2.5g | Indicated for septicemia, lower respiratory tract infections, intra-abdominal and biliary tract infections, complicated urinary tract infections, and severe skin and soft-tissue infections caused by susceptible Gram-negative bacilli. It is especially suitable for infections in immunocompromised patients, nosocomial infections caused by multidrug-resistant Gram-negative bacilli, and central nervous system infections caused by Gram-negative bacilli or Pseudomonas aeruginosa. | JP, CN | Dist |
| Cefuroxime Axetil Tablets | 0.125g; 0.25g | Cefuroxime Axetil is indicated for the treatment of infections caused by susceptible bacteria. - Lower respiratory tract infections: such as acute bronchitis, acute exacerbations of chronic bronchitis, and pneumonia. - Upper respiratory tract infections: including infections of the ear, nose, and throat, such as otitis media, sinusitis, tonsillitis, and pharyngitis. - Genitourinary tract infections: such as pyelonephritis, cystitis, and urethritis. - Skin and soft tissue infections: such as impetigo, pyoderma, and pustular diseases. - Gonorrhea: acute uncomplicated gonococcal urethritis and cervicitis. | CN | Dist |
| Clarithromycin Tablets | 0.25g | Upper and lower respiratory tract infections; skin and soft tissue infections; localized or diffuse infections; mixed infections; odontogenic infections; eradication of Helicobacter pylori. | CN | Dist |
| Daptomycin for Injection | 500mg | Complicated skin and skin structure infections | US, CN | Dist |
| Daptomycin for Injection | 0.5g | This product is indicated for the treatment of the following infections: - Complicated skin and soft tissue infections (cSSSI). - Bloodstream infections (bacteremia) caused by Staphylococcus aureus (including both methicillin-susceptible and methicillin-resistant strains) in adults, as well as associated right-sided infective endocarditis. - Bloodstream infections (bacteremia) caused by Staphylococcus aureus in pediatric patients (ages 1 to 17 years). | CN, US | Dist |
| Entecavir Tablets | 0.5mg; 1.0mg | Chronic hepatitis B for patients with active viral replication, histological evidence of active disease, or persistent elevations in liver transaminases. | CN, EU, US | Dist |
| Human Immunoglobulin (pH4) for Intravenous Injection | 1.25g/vial (5%, 25mL); 2.5g/vial (5%, 50mL); 5g/vial (5%, 100mL) | Primary immune globulin deficiency; secondary immunoglobulin deficiency; autoimmune diseases | CN | Dist |
| Human Rabies Immunoglobulin | 200IU (2mL) | Passive immunity of patients bitten and scratched by rabies or other animals | CN | Dist |
| Imipenem and Cilastatin Sodium for Injection | 0.25g: 0.25g; 0.5g: 0.5g | This product is used for various infections caused by susceptible bacteria, and is especially suitable for mixed infections caused by multiple bacteria and by both aerobic and anaerobic bacteria, such as peritonitis, hepatobiliary infections, intra-abdominal abscesses, appendicitis, gynecological infections, lower respiratory tract infections, skin and soft tissue infections, urinary tract infections, bone and joint infections, and sepsis. | CN | Dist |
| Isavuconazonium Sulfate for Injection | 200mg | Invasive aspergillosis and mucormycosis | CN | Dist |
| Micafungin Sodium for Injection | 50mg | Infections caused by Aspergillus and Candida species, including: - Fungal bloodstream infections (fungemia) - Respiratory tract mycoses - Gastrointestinal mycoses | CN | Dist |
| Piperacillin Sodium and Tazobactam Sodium for Injection | 0.5g: 0.125g; 1.0g: 0.25g; 2.0g: 0.5g; 0.5g: 0.0625g; 1.0g: 0.125g; 2.0g: 0.25g; 3.0g; 0.375g; 4.0g: 0.5g | This product is indicated for moderate to severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but susceptible to piperacillin/tazobactam. 1. Appendicitis (with perforation or abscess) and peritonitis caused by piperacillin-resistant, β-lactamase-producing Escherichia coli and Bacteroides spp. (including Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron, or Bacteroides vulgatus). 2. Non-complex and complex skin and soft tissue infections, including cellulitis, skin abscesses, and ischemic or diabetic foot infections, caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. 3. Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β-lactamase-producing Escherichia coli. 4. Community-acquired pneumonia (moderate only) caused by piperacillin-resistant, β-lactamase-producing Haemophilus influenzae. 5. Moderate to severe hospital-acquired pneumonia (nosocomial pneumonia) caused by piperacillin-resistant, β-lactamase-producing Staphylococcus aureus. Treatment of systemic and/or localized bacterial infections caused by susceptible bacteria. | CN | Dist |
| Posaconazole Enteric-coated Tablets | 100mg | Prophylaxis of invasive Aspergillus and Candida Infections. | US, CN | Dist |
| Pradefovir Mesylate Tablets | 45mg | Hepatitis B | CN | Dist |
